Cargando…
Immune checkpoint inhibitors for the treatment of non-small cell lung cancer brain metastases
Lung cancer has the highest risk of brain metastasis (BM) among all solid carcinomas. The emergence of BM has a significant impact on the selection of oncologic treatment for patients. Immune checkpoint inhibitors (ICIs) are the most promising treatment option for patients without druggable mutation...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325750/ https://www.ncbi.nlm.nih.gov/pubmed/37106555 http://dx.doi.org/10.1097/CM9.0000000000002163 |